<?xml version="1.0" encoding="UTF-8"?>
<xml><bibliography><APA>Pimporn Watcharangkul. (1995) Lipid status in type II hyperlipoproteinemic patients on d1-alpha-tocopheryl nicotinate or 2-[2-(4-chlorophenoxy)-2-methylpropionyloxy] ethyl nicotinate treatment. Mahidol University,:ม.ป.ท.</APA><Chicago>Pimporn Watcharangkul. 1995. Lipid status in type II hyperlipoproteinemic patients on d1-alpha-tocopheryl nicotinate or 2-[2-(4-chlorophenoxy)-2-methylpropionyloxy] ethyl nicotinate treatment. ม.ป.ท.:Mahidol University,;</Chicago><MLA>Pimporn Watcharangkul.  Lipid status in type II hyperlipoproteinemic patients on d1-alpha-tocopheryl nicotinate or 2-[2-(4-chlorophenoxy)-2-methylpropionyloxy] ethyl nicotinate treatment.  ม.ป.ท.:Mahidol University, 1995. Print.</MLA></bibliography></xml>
